The BEST Registry

The primary objective of the BEST-Registry is to enroll patients excluded from the BEST-CLI Trial and thereby assess real-world therapeutic strategies, clinical outcomes, and costs associated with critical limb ischemia. By enrolling patients excluded from the BEST-CLI trial, data from the BEST-Registry will also provide important context to the results of the BEST-CLI Trial.

Principal Investigator: Dr. Zayed Mohamed
Study Coordinator: Kelley Chadwick-Mansker

This study is actively enrolling. To learn more about BEST-registry and how you can join contact our research office at (314) 289-7690

This study is funded by the Foundation through NHLBI (the National Heart Lung and Blood Institute)